Verve Therapeutics, Inc. (NASDAQ: VERV) Stock Information | RedChip

Verve Therapeutics, Inc. (NASDAQ: VERV)


$6.0100
N/A ( -4.45% ) 1.3M

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

Market Data


Open


$6.0100

Previous close


$6.0100

Volume


1.3M

Market cap


$508.83M

Day range


$5.9950 - $6.5330

52 week range


$4.3050 - $19.3400

SEC Filings


Form Type Description Pages Date
3 Insider transactions 2 Jun 28, 2024
8-k/a 8K-related 13 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024

Latest News